We are live on ! Find out more
PL

Pluribus Labs Portfolio holdings

AUM $54.8M
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25.2M
AUM Growth
-$69.7M
Cap. Flow
-$68.8M
Cap. Flow %
-273.42%
Top 10 Hldgs %
58.31%
Holding
244
New
16
Increased
13
Reduced
15
Closed
200

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$505K
2
BLK icon
Blackrock
BLK
+$373K
3
PLD icon
Prologis
PLD
+$358K
4
IBM icon
IBM
IBM
+$321K
5
LMT icon
Lockheed Martin
LMT
+$310K

Sector Composition

Rank Sector Weight
1 Technology 32%
2 Consumer Discretionary 15.05%
3 Healthcare 13.51%
4 Communication Services 13.02%
5 Financials 12.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XRX icon
226
Xerox
XRX
$357M
-20,021
Closed -$453K
ZBRA icon
227
Zebra Technologies
ZBRA
$12.6B
-352
Closed -$210K
ZM icon
228
Zoom
ZM
$26.5B
-1,443
Closed -$265K
QVCGA
229
DELISTED
QVC Group Inc Series A
QVCGA
-2,140
Closed -$813K
NKLA
230
DELISTED
Nikola Corporation Common Stock
NKLA
-732
Closed -$217K
VGR
231
DELISTED
Vector Group Ltd.
VGR
-16,157
Closed -$185K
PWSC
232
DELISTED
PowerSchool Holdings, Inc.
PWSC
-13,476
Closed -$222K
BIG
233
DELISTED
Big Lots, Inc.
BIG
-5,529
Closed -$249K
AMK
234
DELISTED
AssetMark Financial Holdings, Inc.
AMK
-14,191
Closed -$372K
TWOU
235
DELISTED
2U Inc
TWOU
-424
Closed -$256K
TRTN
236
DELISTED
Triton International Limited
TRTN
-3,906
Closed -$235K
SYNH
237
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-3,801
Closed -$390K
ARNC
238
DELISTED
Arconic Corporation
ARNC
-9,479
Closed -$313K
SGFY
239
DELISTED
Signify Health, Inc.
SGFY
-10,877
Closed -$155K
ABMD
240
DELISTED
Abiomed Inc
ABMD
-928
Closed -$333K
CERN
241
DELISTED
Cerner Corp
CERN
-2,734
Closed -$254K
ZNGA
242
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-25,374
Closed -$162K
SWI
243
DELISTED
SolarWinds Corporation Common Stock
SWI
-38,584
Closed -$548K
SBNY
244
DELISTED
Signature Bank
SBNY
-761
Closed -$246K

Similar funds

Pluribus Labs's Q1 2022 Portfolio in Review

As of Q1 2022, Pluribus Labs held 244 positions worth $25.2M, down 73% from $94.8M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Pluribus Labs withdrew a net $68.8M in Q1 2022, closing 200 positions and reducing 15 holdings. Its most notable exit was Marsh, an estimated $1.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Pluribus Labs opened a new position in Merck worth $526K.

  • Pluribus Labs's largest Q1 2022 buy was Merck: 6,405 shares worth $526K.
  • Pluribus Labs added most to Apple in Q1 2022, an estimated $289K increase.
  • Pluribus Labs's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $647K.
  • Pluribus Labs fully exited Marsh in Q1 2022, selling an estimated $1.04M.
  • Pluribus Labs's ten largest holdings make up 58% of its $25.2M portfolio in Q1 2022.
  • Pluribus Labs opened 16 new positions and closed 200 in Q1 2022.
  • Pluribus Labs's portfolio value fell 73% quarter-over-quarter to $25.2M.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.